Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117671472 | 11767147 | 2 | F | 20150612 | 20160830 | 20151123 | 20160912 | EXP | IT-JNJFOC-20151120024 | JANSSEN | 74.43 | YR | E | M | Y | 0.00000 | 20160912 | MD | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117671472 | 11767147 | 1 | PS | ABIRATERONE ACETATE | ABIRATERONE ACETATE | 1 | Oral | Y | N | 202379 | 1000 | MG | TABLET | ||||||
117671472 | 11767147 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | Y | 0 | 5 | MG | TABLET | BID | ||||||
117671472 | 11767147 | 3 | C | OLAPARIB | OLAPARIB | 1 | Oral | 0 | TABLET | ||||||||||
117671472 | 11767147 | 4 | C | LANSOX | LANSOPRAZOLE | 1 | Oral | 0 | 30 | MG | UNSPECIFIED | QD | |||||||
117671472 | 11767147 | 5 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 0 | 50 | MG | UNSPECIFIED | BID | |||||||
117671472 | 11767147 | 6 | C | DIGOSSINA | 2 | Oral | 0 | .125 | MG | UNKNOWN | QD | ||||||||
117671472 | 11767147 | 7 | C | TAO | TROLEANDOMYCIN | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
117671472 | 11767147 | 8 | C | APO-GLICLAZIDE | GLICLAZIDE | 1 | Oral | 0 | 30 | MG | UNSPECIFIED | TID | |||||||
117671472 | 11767147 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | 25 | MG | UNSPECIFIED | QD | |||||||
117671472 | 11767147 | 10 | C | KANRENOL | CANRENOATE POTASSIUM | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
117671472 | 11767147 | 11 | C | TARGIN | NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | UNSPECIFIED | ||||||||
117671472 | 11767147 | 12 | C | METOCLOPRAMIDE HYDROCHLORIDE. | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | UNSPECIFIED | TID | |||||||
117671472 | 11767147 | 13 | C | METOCLOPRAMIDE HYDROCHLORIDE. | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | UNSPECIFIED | TID | |||||||
117671472 | 11767147 | 14 | C | LEUPRORELIN ACETATE | LEUPROLIDE ACETATE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
117671472 | 11767147 | 1 | Prostate cancer metastatic |
117671472 | 11767147 | 2 | Prostate cancer metastatic |
117671472 | 11767147 | 3 | Prostate cancer metastatic |
117671472 | 11767147 | 4 | Gastrointestinal disorder therapy |
117671472 | 11767147 | 5 | Hypertension |
117671472 | 11767147 | 6 | Hypertension |
117671472 | 11767147 | 7 | Hypertension |
117671472 | 11767147 | 8 | Diabetes mellitus |
117671472 | 11767147 | 9 | Hypertension |
117671472 | 11767147 | 10 | Hypertension |
117671472 | 11767147 | 11 | Back pain |
117671472 | 11767147 | 12 | Nausea |
117671472 | 11767147 | 13 | Vomiting |
117671472 | 11767147 | 14 | Chemotherapy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
117671472 | 11767147 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
117671472 | 11767147 | Nausea | |
117671472 | 11767147 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
117671472 | 11767147 | 1 | 20150427 | 20150612 | 0 | |
117671472 | 11767147 | 2 | 20150427 | 20150612 | 0 | |
117671472 | 11767147 | 3 | 20150427 | 20150612 | 0 | |
117671472 | 11767147 | 12 | 20150520 | 20150708 | 0 | |
117671472 | 11767147 | 13 | 20150520 | 20150708 | 0 | |
117671472 | 11767147 | 14 | 20110824 | 0 |